Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3593154 Target Snapshot

3-hydroxy-3-methylglutaryl-coenzyme A reductase · SINGLE PROTEIN · Sus scrofa

48Compounds
4Assays
1Approved Drugs
52.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q1W675. Use UniProt Q1W675 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q1W675 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 3-hydroxy-3-methylglutaryl-coenzyme A reductase as ChEMBL target CHEMBL3593154, mapped to UniProt Q1W675. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
3-hydroxy-3-methylglutaryl-coenzyme A reductase
SINGLE PROTEIN · Sus scrofa
As of 2026-09-13
ChEMBL target ID
CHEMBL3593154
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q1W675
3-hydroxy-3-methylglutaryl-coenzyme A reductase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 3-hydroxy-3-methylglutaryl-coenzyme A reductase is the right protein anchor across sources, using UniProt Q1W675 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label3-hydroxy-3-methylglutaryl-coenzyme A reductase
UniProt AccessionQ1W675
Component TypeProtein
Sequence Length885 aa

3-hydroxy-3-methylglutaryl-coenzyme A reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 3-hydroxy-3-methylglutaryl-coenzyme A reductase, mapped to UniProt Q1W675. Sequence length is 885 aa.

Mapped IDQ1W675
Review name3-hydroxy-3-methylglutaryl-coenzyme A reductase
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5052.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1487 6.03 IC50 930.0 Approved
CHEMBL4204041 5.24 IC50 5820.0 Preclinical
CHEMBL4206214 5.21 IC50 6210.0 Preclinical
CHEMBL4215012 5.17 IC50 6760.0 Preclinical
CHEMBL4209384 5.13 IC50 7430.0 Preclinical
CHEMBL1915760 5.07 IC50 8600.0 Preclinical
CHEMBL4204038 5.05 IC50 8900.0 Preclinical
CHEMBL1099224 5.02 IC50 9500.0 Preclinical
CHEMBL3594152 4.97 IC50 10700.0 Preclinical
CHEMBL4096720 4.91 IC50 12300.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
0
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ATORVASTATIN
CHEMBL1487
Approved 1996
Assay Landscape

Assay Landscape

4
Total Assays
35
Tested Compounds
1
Assay Types
Binding — 4 assays, 35 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 35 4.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine